This Article Full Text Full Text (PDF) Online Supplement All Versions of this Article: 200506-859OCv1 173/10/1114    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Papi, A. Articles by Johnston, S. L. Search for Related Content PubMed PubMed Citation Articles by Papi, A. Articles by Johnston, S. L.

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

Research Center on Asthma and COPD, University of Ferrara, Ferrara; Section of Respiratory Diseases, University of Modena and Reggio Emilia, Modena, Italy; and National Heart and Lung Institute, Imperial College London, London, United Kingdom

Correspondence and requests for reprints should be addressed to Leonardo M. Fabbri, M.D., Department of Respiratory Diseases, University of Modena and Reggio Emilia, Via del Pozzo 71, I-41100 Modena, Italy. E-mail: fabbri.leonardo{at}unimo.it

Rationale: Severe exacerbations of chronic obstructive pulmonary disease (COPD) are major causes of health care costs mostly related to hospitalization. The role of infections in COPD exacerbations is controversial.

Objectives: We investigated whether COPD exacerbations requiring hospitalization are associated with viral and/or bacterial infection and evaluated relationships among infection, exacerbation severity, assessed by reduction of FEV₁, and specific patterns of airway inflammation.

Methods: We examined 64 patients with COPD when hospitalized for exacerbations, and when in stable convalescence. We measured lung function, blood gases, and exhaled nitric oxide, and examined sputum for inflammation and for viral and bacterial infection.

Results: Exacerbations were associated with impaired lung function (p < 0.01) and increased sputum neutrophilia (p < 0.001). Viral and/or bacterial infection was detected in 78% of exacerbations: viruses in 48.4% (6.2% when stable, p < 0.001) and bacteria in 54.7% (37.5% when stable, p = 0.08). Patients with infectious exacerbations (29.7% bacterial, 23.4% viral, 25% viral/bacterial coinfection) had longer hospitalizations (p < 0.02) and greater impairment of several measures of lung function (all p < 0.05) than those with noninfectious exacerbations. Patients with exacerbations with coinfection had more marked lung function impairment (p < 0.02) and longer hospitalizations (p = 0.001). Sputum neutrophils were increased in all exacerbations (p < 0.001) and were related to their severity (p < 0.001), independently of the association with viral or bacterial infections; sputum eosinophils were increased during (p < 0.001) virus-associated exacerbations.

Conclusions: Respiratory infections are associated with the majority of COPD exacerbations and their severity, especially those with viral/bacterial coinfection. Airway neutrophilia is related to exacerbation severity regardless of viral and/or bacterial infections. Eosinophilia is a good predictor of viral exacerbations.

Key Words: airway inflammation • bacteria • chronic obstructive pulmonary disease • respiratory viruses • severe exacerbations

This article has been cited by other articles:

				C. Garcia-Vidal, P. Almagro, V. Romani, M. Rodriguez-Carballeira, E. Cuchi, L. Canales, D. Blasco, J. L. Heredia, and J. Garau Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study Eur. Respir. J., November 1, 2009; 34(5): 1072 - 1078. [Abstract] [Full Text] [PDF]

				M. R. Loebinger, A. U. Wells, D. M. Hansell, N. Chinyanganya, A. Devaraj, M. Meister, and R. Wilson Mortality in bronchiectasis: a long-term study assessing the factors influencing survival Eur. Respir. J., October 1, 2009; 34(4): 843 - 849. [Abstract] [Full Text] [PDF]

				S. Sethi, P. Mallia, and S. L. Johnston New Paradigms in the Pathogenesis of Chronic Obstructive Pulmonary Disease II Proceedings of the ATS, September 15, 2009; 6(6): 532 - 534. [Abstract] [Full Text] [PDF]

				C. Crim, P. M. A. Calverley, J. A. Anderson, B. Celli, G. T. Ferguson, C. Jenkins, P. W. Jones, L. R. Willits, J. C. Yates, and J. Vestbo Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results Eur. Respir. J., September 1, 2009; 34(3): 641 - 647. [Abstract] [Full Text] [PDF]

				D. A. Lomas, E. K. Silverman, L. D. Edwards, N. W. Locantore, B. E. Miller, D. H. Horstman, R. Tal-Singer, and on behalf of the Evaluation of COPD Longitudinally Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD Eur. Respir. J., July 1, 2009; 34(1): 95 - 102. [Abstract] [Full Text] [PDF]

				A. Haegens, P. Heeringa, R. J. van Suylen, C. Steele, Y. Aratani, R. J. J. O'Donoghue, S. E. Mutsaers, B. T. Mossman, E. F. M. Wouters, and J. H. J. Vernooy Myeloperoxidase Deficiency Attenuates Lipopolysaccharide-Induced Acute Lung Inflammation and Subsequent Cytokine and Chemokine Production J. Immunol., June 15, 2009; 182(12): 7990 - 7996. [Abstract] [Full Text] [PDF]

				J Garbino, P M Soccal, J-D Aubert, T Rochat, P Meylan, Y Thomas, C Tapparel, P-O Bridevaux, and L Kaiser Respiratory viruses in bronchoalveolar lavage: a hospital-based cohort study in adults Thorax, May 1, 2009; 64(5): 399 - 404. [Abstract] [Full Text] [PDF]

				W. Janssens, A. Lehouck, C. Carremans, R. Bouillon, C. Mathieu, and M. Decramer Vitamin D Beyond Bones in Chronic Obstructive Pulmonary Disease: Time to Act Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 630 - 636. [Abstract] [Full Text] [PDF]

				G. J. Gaschler, M. Skrtic, C. C. J. Zavitz, M. Lindahl, P.-O. Onnervik, T. F. Murphy, S. Sethi, and M. R. Stampfli Bacteria Challenge in Smoke-exposed Mice Exacerbates Inflammation and Skews the Inflammatory Profile Am. J. Respir. Crit. Care Med., April 15, 2009; 179(8): 666 - 675. [Abstract] [Full Text] [PDF]

				P.-R. Burgel, P. Nesme-Meyer, P. Chanez, D. Caillaud, P. Carre, T. Perez, N. Roche, and on behalf of the Initiatives Bronchopneumopathie C Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects Chest, April 1, 2009; 135(4): 975 - 982. [Abstract] [Full Text] [PDF]

				T. A. R. Seemungal, T. M. A. Wilkinson, J. R. Hurst, W. R. Perera, R. J. Sapsford, and J. A. Wedzicha Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1139 - 1147. [Abstract] [Full Text] [PDF]

				S. Sethi and T. F. Murphy Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., November 27, 2008; 359(22): 2355 - 2365. [Full Text] [PDF]

				J. A Wedzicha Antibiotics at COPD exacerbations: the debate continues Thorax, November 1, 2008; 63(11): 940 - 942. [Full Text] [PDF]

				A. Papi, M. Contoli, P. Gasparini, L. Bristot, M. R. Edwards, M. Chicca, M. Leis, A. Ciaccia, G. Caramori, S. L. Johnston, et al. Role of Xanthine Oxidase Activation and Reduced Glutathione Depletion in Rhinovirus Induction of Inflammation in Respiratory Epithelial Cells J. Biol. Chem., October 17, 2008; 283(42): 28595 - 28606. [Abstract] [Full Text] [PDF]

				T. Seemungal, A. Sykes, and and the ICEAD Contributors Recent advances in exacerbations of COPD Thorax, October 1, 2008; 63(10): 850 - 852. [Full Text] [PDF]

				M. E. Falagas, S. G. Avgeri, D. K. Matthaiou, G. Dimopoulos, and I. I. Siempos Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis J. Antimicrob. Chemother., September 1, 2008; 62(3): 442 - 450. [Abstract] [Full Text] [PDF]

				Z. L. Borrill, K. Roy, and D. Singh Exhaled breath condensate biomarkers in COPD Eur. Respir. J., August 1, 2008; 32(2): 472 - 486. [Abstract] [Full Text] [PDF]

				K. F. Chung and I. M. Adcock Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur. Respir. J., June 1, 2008; 31(6): 1334 - 1356. [Abstract] [Full Text] [PDF]

				B G G Oliver, S Lim, P Wark, V Laza-Stanca, N King, J L Black, J K Burgess, M Roth, and S L Johnston Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages Thorax, June 1, 2008; 63(6): 519 - 525. [Abstract] [Full Text] [PDF]

				N. MacIntyre and Y. C. Huang Acute Exacerbations and Respiratory Failure in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 530 - 535. [Abstract] [Full Text] [PDF]

				T. Manolov, T. T. Tan, A. Forsgren, and K. Riesbeck Moraxella-Dependent {alpha}1-Antichymotrypsin Neutralization: A Unique Virulence Mechanism Am. J. Respir. Cell Mol. Biol., May 1, 2008; 38(5): 609 - 617. [Abstract] [Full Text] [PDF]

				I Sabroe, L C Parker, P M A Calverley, S K Dower, and M K B Whyte Pathological networking: a new approach to understanding COPD Postgrad. Med. J., May 1, 2008; 84(991): 259 - 264. [Abstract] [Full Text] [PDF]

				W. MacNee Update in Chronic Obstructive Pulmonary Disease 2007 Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 820 - 829. [Full Text] [PDF]

				T. F. Murphy, A. L. Brauer, K. Eschberger, P. Lobbins, L. Grove, X. Cai, and S. Sethi Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 853 - 860. [Abstract] [Full Text] [PDF]

				K. Liu, R. C. Gualano, M. L. Hibbs, G. P. Anderson, and S. Bozinovski Epidermal Growth Factor Receptor Signaling to Erk1/2 and STATs Control the Intensity of the Epithelial Inflammatory Responses to Rhinovirus Infection J. Biol. Chem., April 11, 2008; 283(15): 9977 - 9985. [Abstract] [Full Text] [PDF]

				S. Sethi, C. Wrona, K. Eschberger, P. Lobbins, X. Cai, and T. F. Murphy Inflammatory Profile of New Bacterial Strain Exacerbations of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 1, 2008; 177(5): 491 - 497. [Abstract] [Full Text] [PDF]

				G. J. Gaschler, C. C. J. Zavitz, C. M. T. Bauer, M. Skrtic, M. Lindahl, C. S. Robbins, B. Chen, and M. R. Stampfli Cigarette Smoke Exposure Attenuates Cytokine Production by Mouse Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 218 - 226. [Abstract] [Full Text] [PDF]

				S. Bozinovski, A. Hutchinson, M. Thompson, L. MacGregor, J. Black, E. Giannakis, A.-S. Karlsson, R. Silvestrini, D. Smallwood, R. Vlahos, et al. Serum Amyloid A Is a Biomarker of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., February 1, 2008; 177(3): 269 - 278. [Abstract] [Full Text] [PDF]

				G. P. Anderson The COPD CO-factor Eur. Respir. J., December 1, 2007; 30(6): 1032 - 1034. [Full Text] [PDF]

				I. Sabroe, L. C. Parker, S. K. Dower, and M. K. B. Whyte Practical and Conceptual Models of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2007; 4(8): 606 - 610. [Abstract] [Full Text] [PDF]

				H. Abusriwil and R. A. Stockley The Interaction of Host and Pathogen Factors in Chronic Obstructive Pulmonary Disease Exacerbations and Their Role in Tissue Damage Proceedings of the ATS, December 1, 2007; 4(8): 611 - 617. [Abstract] [Full Text] [PDF]

				A. Sykes, P. Mallia, and S. L. Johnston Diagnosis of Pathogens in Exacerbations of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2007; 4(8): 642 - 646. [Abstract] [Full Text] [PDF]

				F. J. Martinez Pathogen-directed Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 1, 2007; 4(8): 647 - 658. [Abstract] [Full Text] [PDF]

				E. Bathoorn, D-J. Slebos, D. S. Postma, G. H. Koeter, A. J. M. van Oosterhout, M. van der Toorn, H. M. Boezen, and H. A. M. Kerstjens Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study Eur. Respir. J., December 1, 2007; 30(6): 1131 - 1137. [Abstract] [Full Text] [PDF]

				M. Miravitlles Review: Do we need new antibiotics for treating exacerbations of COPD? Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 61 - 76. [Abstract] [PDF]

				A. Anzueto, S. Sethi, and F. J. Martinez Exacerbations of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, October 1, 2007; 4(7): 554 - 564. [Abstract] [Full Text] [PDF]

				A. Canut, J. E. Martin-Herrero, A. Labora, and H. Maortua What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model J. Antimicrob. Chemother., September 1, 2007; 60(3): 605 - 612. [Abstract] [Full Text] [PDF]

				T. M. A. Wilkinson Host Pathogen Interactions during COPD Exacerbations: Moving on from Microbiology by Numbers? Am. J. Respir. Crit. Care Med., August 15, 2007; 176(4): 323 - 325. [Full Text] [PDF]

				A. Singh Inhaled steroids in exacerbations of COPD Eur. Respir. J., August 1, 2007; 30(2): 398 - 398. [Full Text] [PDF]

				I. Sabroe, L. C Parker, P. M A Calverley, S. K Dower, and M. K B Whyte Pathological networking: a new approach to understanding COPD Thorax, August 1, 2007; 62(8): 733 - 738. [Abstract] [Full Text] [PDF]

				K. F. Rabe, B. Beghe, F. Luppi, and L. M. Fabbri Update in Chronic Obstructive Pulmonary Disease 2006 Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1222 - 1232. [Full Text] [PDF]

				B. R. Celli and P. J. Barnes Exacerbations of chronic obstructive pulmonary disease Eur. Respir. J., June 1, 2007; 29(6): 1224 - 1238. [Abstract] [Full Text] [PDF]

				M. R. Edwards, J. Haas, R. A. Panettieri Jr., M. Johnson, and S. L. Johnston Corticosteroids and beta2 Agonists Differentially Regulate Rhinovirus-induced Interleukin-6 via Distinct Cis-acting Elements J. Biol. Chem., May 25, 2007; 282(21): 15366 - 15375. [Abstract] [Full Text] [PDF]

				J A Wedzicha and J R Hurst Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism Thorax, February 1, 2007; 62(2): 103 - 104. [Full Text] [PDF]

				F. W.S. Ko, M. Ip, P. K.S. Chan, J. P.C. Fok, M. C.H. Chan, J. C. Ngai, D. P.S. Chan, and D. S.C. Hui A 1-Year Prospective Study of the Infectious Etiology in Patients Hospitalized With Acute Exacerbations of COPD Chest, January 1, 2007; 131(1): 44 - 52. [Abstract] [Full Text] [PDF]

				L. Kaiser, J.-D. Aubert, J.-C. Pache, C. Deffernez, T. Rochat, J. Garbino, W. Wunderli, P. Meylan, S. Yerly, L. Perrin, et al. Chronic Rhinoviral Infection in Lung Transplant Recipients Am. J. Respir. Crit. Care Med., December 15, 2006; 174(12): 1392 - 1399. [Abstract] [Full Text] [PDF]

				E. Puchelle, J.-M. Zahm, J.-M. Tournier, and C. Coraux Airway Epithelial Repair, Regeneration, and Remodeling after Injury in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2006; 3(8): 726 - 733. [Abstract] [Full Text] [PDF]

				P. Mallia and S. L. Johnston How viral infections cause exacerbation of airway diseases. Chest, October 1, 2006; 130(4): 1203 - 1210. [Abstract] [Full Text] [PDF]

				Severe COPD Exacerbations Associated with Viruses and Bacteria Journal Watch Infectious Diseases, June 9, 2006; 2006(609): 8 - 8. [Full Text]